Strola G - Search Results

1

Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.

Falco P, Levis A, Stacchini A, Ciriello MM, Geuna M, Notari P, Omedè P, Pautasso M, Prato G, Strola G, Gioia D, Bonferroni M, Cametti G, Ferrero D, Freilone R, Gaidano G, Marinone C, Marmont F, Pollio B, Salvi F, Saglio G, Girotto M; Piedmont MDS Registry--Italy. Falco P, et al. Among authors: strola g. Eur J Haematol. 2011 Nov;87(5):409-18. doi: 10.1111/j.1600-0609.2011.01676.x. Epub 2011 Aug 11. Eur J Haematol. 2011. PMID: 21711395

2

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.

Ghia P, Guida G, Stella S, Gottardi D, Geuna M, Strola G, Scielzo C, Caligaris-Cappio F. Ghia P, et al. Among authors: strola g. Blood. 2003 Feb 15;101(4):1262-9. doi: 10.1182/blood-2002-06-1801. Epub 2002 Oct 24. Blood. 2003. PMID: 12406914 Free article.

3

Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

Ghia P, Strola G, Granziero L, Geuna M, Guida G, Sallusto F, Ruffing N, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F. Ghia P, et al. Among authors: strola g. Eur J Immunol. 2002 May;32(5):1403-13. doi: 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y. Eur J Immunol. 2002. PMID: 11981828 Free article.

4

p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection.

Marinone C, Martinetti A, Mestriner M, Seregni E, Geuna M, Ferrari L, Strola G, Bonardi L, Fea E, Bombardieri E. Marinone C, et al. Among authors: strola g. Anticancer Res. 2001 Mar-Apr;21(2A):1115-8. Anticancer Res. 2001. PMID: 11396149

5

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.

Elba S, Castellino A, Soriasio R, Castellino C, Bonferroni M, Mattei D, Strola G, Drandi D, Mordini N, Foglietta M, Rapezzi D, Celeghini I, Grasso M, Giordano F, Fraternali Orcioni G, Massaia M. Elba S, et al. Among authors: strola g. J Med Case Rep. 2020 Jun 22;14(1):75. doi: 10.1186/s13256-020-02380-2. J Med Case Rep. 2020. PMID: 32564775 Free PMC article.

6

Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience.

Sorasio R, Bonferroni M, Grasso M, Strola G, Rapezzi D, Marenchino D, Di Marco C, Castellino C, Mattei D, Mordini N, Fiore F, Celeghini I, Borra A, Ghiglia A, Gallamini A. Sorasio R, et al. Among authors: strola g. Biol Blood Marrow Transplant. 2014 May;20(5):717-23. doi: 10.1016/j.bbmt.2014.02.002. Epub 2014 Feb 11. Biol Blood Marrow Transplant. 2014. PMID: 24525280 Free article. Clinical Trial.

7

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia.

Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F. Granziero L, et al. Among authors: strola g. Blood. 2001 May 1;97(9):2777-83. doi: 10.1182/blood.v97.9.2777. Blood. 2001. PMID: 11313271 Free article.

8

The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation.

Cignetti A, Vallario A, Roato I, Circosta P, Strola G, Scielzo C, Allione B, Garetto L, Caligaris-Cappio F, Ghia P. Cignetti A, et al. Among authors: strola g. Exp Hematol. 2003 Jun;31(6):495-503. doi: 10.1016/s0301-472x(03)00066-3. Exp Hematol. 2003. PMID: 12829025 Free article.

9

CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells.

Husson H, Freedman AS, Cardoso AA, Schultze J, Munoz O, Strola G, Kutok J, Carideo EG, De Beaumont R, Caligaris-Cappio F, Ghia P. Husson H, et al. Among authors: strola g. Br J Haematol. 2002 Nov;119(2):492-5. doi: 10.1046/j.1365-2141.2002.03832.x. Br J Haematol. 2002. PMID: 12406091 Free article.

10

The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients.

Monteverde M, Milano G, Strola G, Maffi M, Lattanzio L, Vivenza D, Tonissi F, Merlano M, Lo Nigro C. Monteverde M, et al. Among authors: strola g. Crit Rev Oncol Hematol. 2015 Aug;95(2):179-90. doi: 10.1016/j.critrevonc.2015.02.014. Epub 2015 Mar 12. Crit Rev Oncol Hematol. 2015. PMID: 25819749 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page